In summary, these experiments have shown that there are significant differences in the proportions, subsets, intracellular proteins and cytotoxic abilities of CD56+CD3- (natural killer; NK) cells and CD56+CD3+ (NKT-like) cells in the peripheral blood of COPD subjects. This evidence concerns the gene NCAM1 and chronic obstructive pulmonary disease.